Top compounds associated with response to APOD


Feature Type Standardized
Nominal ANOVA
mRNA Cyclopamine GDSC1000 pan-cancer AAC 0.052 0.4
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.031 0.4
mRNA Nilotinib CCLE pan-cancer AAC -0.055 0.4
mRNA SID 26681509 CTRPv2 pan-cancer AAC -0.036 0.4
mRNA PDMP CTRPv2 pan-cancer AAC 0.036 0.4
mRNA niclosamide CTRPv2 pan-cancer AAC 0.034 0.4
mRNA EX-527 CTRPv2 pan-cancer AAC -0.037 0.4
mRNA Gefitinib FIMM pan-cancer AAC -0.15 0.4
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.031 0.4
mRNA Cyclopamine FIMM pan-cancer AAC -0.14 0.4
Download CSV